BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 215 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,915,717 | +9.3% | 5,040,414 | -28.7% | 0.01% | +16.7% |
Q2 2023 | $121,592,992 | +42.6% | 7,069,360 | +37.5% | 0.01% | +20.0% |
Q1 2023 | $85,271,156 | -36.7% | 5,143,013 | -70.9% | 0.01% | +25.0% |
Q4 2022 | $134,796,932 | +70.7% | 17,689,886 | +122.7% | 0.00% | -20.0% |
Q3 2022 | $78,952,000 | -20.6% | 7,942,811 | -27.5% | 0.01% | -16.7% |
Q2 2022 | $99,490,000 | +6.5% | 10,957,063 | +19.0% | 0.01% | +20.0% |
Q1 2022 | $93,443,000 | +59.0% | 9,206,234 | +161.4% | 0.01% | +66.7% |
Q4 2021 | $58,755,000 | -59.4% | 3,522,463 | +14.2% | 0.00% | -62.5% |
Q3 2021 | $144,540,000 | -10.6% | 3,083,859 | +16.2% | 0.01% | -11.1% |
Q2 2021 | $161,757,000 | +11.0% | 2,653,496 | +12.2% | 0.01% | +12.5% |
Q1 2021 | $145,707,000 | -10.8% | 2,365,372 | +3.0% | 0.01% | -20.0% |
Q4 2020 | $163,306,000 | +84.9% | 2,296,523 | -2.5% | 0.01% | +66.7% |
Q3 2020 | $88,341,000 | -15.0% | 2,354,508 | -26.1% | 0.01% | -25.0% |
Q2 2020 | $103,906,000 | +109.1% | 3,186,321 | +85.9% | 0.01% | +100.0% |
Q1 2020 | $49,698,000 | +75.4% | 1,713,716 | +112.0% | 0.00% | +100.0% |
Q4 2019 | $28,329,000 | +275.2% | 808,243 | +129.9% | 0.00% | +100.0% |
Q3 2019 | $7,550,000 | – | 351,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |